Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2024-06-17 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Imfinzi approved in the US for endometrial cancer
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5955S' and is dated '17 June 2024'. It announces a specific regulatory event: the FDA approval of AstraZeneca's drug Imfinzi for endometrial cancer, based on clinical trial results (DUO-E). The content is a press release detailing a significant corporate/product development, not a routine financial filing like a 10-K or an earnings release (ER). Since it is a formal announcement distributed via RNS (the news service of the London Stock Exchange) and concerns a material event, it fits best under the general 'Regulatory Filings' category, which serves as a fallback for important, non-standard announcements not covered by other specific codes (like DIV, CAP, or ER). It is not a Call Transcript (CT), Investor Presentation (IP), or a formal financial report (IR/10-K). Given the source (RNS) and the nature of the announcement (FDA approval), RNS is the most appropriate classification.
2024-06-17 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2024-06-12 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an official notification filed via RNS (RNS Number: 1735S) concerning a 'Transaction by Person Discharging Managerial Responsibilities'. Specifically, it details the gift of shares by the Chief Executive Officer, Pascal Soriot, to family members. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it uses the RNS distribution service, the content is highly specific to insider trading disclosure, making DIRS the most accurate classification over the general RNS fallback.
2024-06-12 English
Acquisition of Fusion completed
M&A Activity Classification · 1% confidence The document is an official announcement released via RNS (RNS Number: 1170R) on June 5, 2024, detailing the successful completion of the acquisition of Fusion Pharmaceuticals Inc. by AstraZeneca. It discusses financial considerations, the transfer of ownership, and subsequent delisting/deregistration actions. This type of corporate action announcement, which is not a periodic financial report (like 10-K or IR), a management discussion (MDA), or a specific shareholder vote result (DVA), fits best under the general category for regulatory news services announcements that don't have a more specific code. Since it is a formal regulatory announcement disseminated through RNS, and it doesn't fit perfectly into CAP (Capital/Financing Update, although it is a transaction, it's primarily a news release about the closing), or TAR (M&A Activity, which usually covers the proposal/bid phase), the most appropriate general regulatory filing category is RNS, as it is explicitly sourced from RNS and serves as a general regulatory disclosure.
2024-06-05 English
FORM 6-K
Foreign Filer Report
2024-06-04 English
Delisting Announcement 2024
Delisting Announcement
2024-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.